These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 22859311

  • 1. Solid lipid nanoparticles of paclitaxel strengthened by hydroxypropyl-β-cyclodextrin as an oral delivery system.
    Baek JS, So JW, Shin SC, Cho CW.
    Int J Mol Med; 2012 Oct; 30(4):953-9. PubMed ID: 22859311
    [Abstract] [Full Text] [Related]

  • 2. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
    Baek JS, Cho CW.
    J Pharm Pharmacol; 2013 Jan; 65(1):72-8. PubMed ID: 23215690
    [Abstract] [Full Text] [Related]

  • 3. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles.
    Agüeros M, Zabaleta V, Espuelas S, Campanero MA, Irache JM.
    J Control Release; 2010 Jul 01; 145(1):2-8. PubMed ID: 20347897
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
    Baek JS, Cho CW.
    Int J Pharm; 2015 Jan 30; 478(2):617-24. PubMed ID: 25510604
    [Abstract] [Full Text] [Related]

  • 7. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles.
    Calleja P, Espuelas S, Vauthier C, Ponchel G, Irache JM.
    J Pharm Sci; 2015 Sep 30; 104(9):2877-86. PubMed ID: 25600579
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP, Wei W, Yue H, Yang TY, Wang LY, Ma GH.
    Biomacromolecules; 2011 Dec 12; 12(12):4230-9. PubMed ID: 22044456
    [Abstract] [Full Text] [Related]

  • 10. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V.
    J Control Release; 2009 Jan 05; 133(1):11-7. PubMed ID: 18950666
    [Abstract] [Full Text] [Related]

  • 11. Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection.
    Baek JS, Kim JH, Park JS, Cho CW.
    Int J Nanomedicine; 2015 Jan 05; 10():5397-405. PubMed ID: 26347363
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy.
    Oh KS, Song JY, Cho SH, Lee BS, Kim SY, Kim K, Jeon H, Kwon IC, Yuk SH.
    J Control Release; 2010 Dec 20; 148(3):344-50. PubMed ID: 20797418
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.